Details of Drug-Drug Interaction
| Drug General Information (ID: DDIXSK041E) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Nicardipine | Drug Info | Vecuronium | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Antihypertensive Agents | Analgesics | |||||||
| Structure | |||||||||
| Mechanism of Nicardipine-Vecuronium Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Decreased renal excretion (Unspecific) Click to Show/Hide Mechanism Graph | |||||||||
| Drug Name | Nicardipine | Vecuronium | |||||||
| Mechanism | Reduce the renal excretion of vecuronium | Vecuronium | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Pharmacokinetics | ||||||||
| Factor Description | Alters the excretion of the drug, resulting in changes in the plasma concentration of the drug and affecting the pharmacological effects. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | Patients should be monitored for excessive and prolonged neuromuscular blockade. One study concluded that a clinical dose of nicardipine reduces vecuronium dosage requirements by as much as 53%. | ||||||||
